Dr Malhotra, who has demanded a full safety review into the use of AstraZeneca's Covid vaccine, told PTI Covishield "should never have been rolled out in the country in the first place".
Serious AESI, which included stroke and Guillain-Barre syndrome, were reported in one per cent of individuals, the study, which looked at long-term safety of the BBV152 vaccine in adolescents and adults, claimed.
Union Health Minister Harsh Vardhan on Friday said the COVID-19 vaccination drive will be extended in the coming days and asserted that there should not be any misconceptions about the two Indian vaccines being administered in the country.
The Medicines and Healthcare Products Regulatory Agency said in its latest Yellow Card monitoring of the coronavirus vaccine programme this week that of the 18.1 million people who had the Oxford vaccine in the UK, 30 people developed blood clots and seven had died as of March 24.
The company has not yet revealed details about the unexplained illness but has stopped trials while doctors find out if the illness was caused due to the vaccine or was a coincidence.
Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through this carefully drawn journey of vaccine development.
While Bharat Biotech's Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been approved for adolescents in the United States; and Cadila Healthcare's ZyCoV-D has done trials on 12 year-olds and above already, reports Sohini Das.
"We have received feedback that certain immunisation centres are recommending taking three paracetamol 500 mg tablets along with Covaxin for children. No paracetamol or painkillers are recommended after being vaccinated with Covaxin," Bharat Biotech said in a Twitter post.
'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'
The Gam-COVID-Vac, called Sputnik V, is a two-part vaccine that includes two adenovirus vectors -- recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S).
In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.
'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar.
'There is a Covid vaccine-mania that is happening in the world now and the vaccine makers are using this mania for their own gains'
A 40-year-old man who was a volunteer in the third phase of the ''Covidshield'' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions.
'The reality of this virus is that as long as it is circulating, it can mutate into new variants and by the time you realise that this is a new virus, which is more dangerous, and more transmissible, it is too late.'
What is foreign policy worth if it stands disconnected from domestic realities? Make no mistake, the horrifying visuals of the human suffering in metropolitan India is only the tip of the iceberg. The vast swathes of the hinterland are heaving with untold sorrows, notes Ambassador M K Bhadrakumar.
'Everyone wants to take a vaccine. The last time a camp was held, there were 1,000 people for 500 doses. People are waiting and returning disappointed. At times, it is creating problems. The demand is much more than the supply.' Ishita Ayan Dutt reports on how the West Bengal countryside is reacting to the vaccination drive.
Loud applause and cheers rang out as the first jabs were administered to frontline workers at hospitals and healthcare centres across the country on Saturday at the start of the gargantuan COVID-19 vaccination exercise, hailed as a 'momentous' occasion in India's fight against the pandemic.
A massive pan-India inoculation drive against COVID-19 was set in process on Tuesday with more than 56 lakh doses of the Covishield vaccine flown to 13 cities across India from Pune and taken to designated national and state-level stores amid tight security.
Senior Congress leader Shashi Tharoor on Thursday said credit should be given to the government for achieving the 100-crore COVID vaccine dose landmark in the country, drawing a sharp response from party colleague Pawan Khera, who asserted that giving credit is an 'insult' to millions of families.
With final preparations underway and the vaccine set to arrive in the national capital in the next couple of days, Rohit Datta, who was the first person to be diagnosed with coronavirus infection on March 1, said "it feels surreal".
'Prevention plus vaccination is what is going to take us into better territory by September or October.'
The Pfizer vaccine has already been approved for the public in the United Kingdom and, Canada.
According to the WHO, countries should join the COVID-19 Vaccine Global Access Facility (COVAX Facility) by September 18 but not later than October 9 with upfront payments.
The Bombay high court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and directed them to delete it.
'I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment since at least 11,500 have got at least one dose by now and it has proven to be safe.'
'SII has started stockpiling the vaccine and now has roughly 40 million doses ready. It is using some of the capacities it had for under development products for the COVID-19 vaccine and by January we will have a capacity to make 100 million doses per month and a stockpile of 200 million doses.'
If people are careful and India is able to vaccinate a large number of population, then the third wave of COVID-19 pandemic may not even come, said All India Institute of Medical Sciences Director Dr Randeep Guleria on Thursday.
'Our client is suffering due to the ill-effects of the vaccine. He has to be compensated for his suffering. Further, a detailed investigation has to be done on the Covishield vaccine and its side-effects,' says the volunteer's advocate.
'There is indeed a link between BCG vaccination and resistance to COVID-19.'
The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.
It would be a trial on children aged 2-18 years for which Bharath Biotech may get the licence in the third quarter of this year.
COVID-19 is on the verge of becoming endemic but Indian scientists are keeping a close watch on each new variant and the government would continue to maintain a high alert, Union health minister Mansukh Mandaviya has said, underlining that the virus has managed to survive and is going to stay.
Amid concerns over dangerous side-effects of the Oxford's COVID-19 vaccine, India is evaluating all serious adverse events post-vaccination to determine the causality aspects of Covishield and Covaxin, an expert associated with the process said on Saturday.
The COVID-19 vaccination drive was successfully conducted on the first day, Additional Secretary in the Union health ministry Manohar Agnani said during a press briefing. Giving an update on COVID-19 vaccination, the health ministry said 3,352 vaccination sessions were held and 1,91,181 beneficiaries vaccinated.
'We know, from our experience of this virus, that there's something known as long COVID-19, where you have this persistent fatigue and some people have lost their neurological acuteness and they are not as sharp as they used to be.'
Modi said he appreciates all doctors, medical staff, and people in administration in the country for this effort.
Reserve Bank Governor Shaktikanta Das has pitched for policy support from all sides -- fiscal, monetary and sectoral -- to nurture recovery of the economy hit by the second wave of the coronavirus pandemic. The dent on economic activity due to the second wave of the pandemic during April-May necessitated continuation of monetary measures to support the process of economic recovery to make it durable, Das had said while participating in the meeting of the Monetary Policy Committee (MPC) earlier in the month. "Overall, the second wave of COVID-19 has altered the near-term outlook, and policy support from all sides - fiscal, monetary and sectoral - is required to nurture recovery and expedite return to normalcy," Das said, as per the minutes of the meeting released on Friday.
'To everyone voting for Trump, I have only this simple question: Would you let him have lunch with your daughter or sister or wife or mother?' 'Then why would you let him have our lunch (and so much more) for four more years?', asks Sree Sreenivasan.
Serum Institute has the capacity to make 250 million doses of Covishield monthly.
